Sean Dodge
Stock Analyst at RBC Capital
(2.06)
# 2,824
Out of 4,835 analysts
133
Total ratings
32.99%
Success rate
-3.54%
Average return
Main Sectors:
Stocks Rated by Sean Dodge
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HCAT Health Catalyst | Maintains: Sector Perform | $7 → $6 | $4.06 | +47.78% | 10 | Feb 27, 2025 | |
| AGL agilon health | Maintains: Outperform | $3 → $3.5 | $2.45 | +42.86% | 7 | Feb 26, 2025 | |
| IQV IQVIA Holdings | Reiterates: Outperform | $270 | $142.82 | +89.05% | 6 | Feb 10, 2025 | |
| TDOC Teladoc Health | Maintains: Outperform | $11 → $12 | $7.52 | +59.57% | 16 | Jan 24, 2025 | |
| ICLR ICON Public Limited Company | Reiterates: Outperform | $263 | $131.63 | +99.80% | 2 | Jan 15, 2025 | |
| EVH Evolent Health | Maintains: Outperform | $20 → $17 | $8.83 | +92.53% | 9 | Jan 14, 2025 | |
| PHR Phreesia | Upgrades: Outperform | $24 → $32 | $25.40 | +25.98% | 15 | Jan 8, 2025 | |
| OPRX OptimizeRx | Downgrades: Sector Perform | $7 → $6 | $11.43 | -47.51% | 11 | Jan 8, 2025 | |
| HQY HealthEquity | Maintains: Outperform | $100 → $105 | $98.23 | +6.89% | 12 | Dec 10, 2024 | |
| SHC Sotera Health Company | Reiterates: Outperform | $17 | $12.80 | +32.81% | 10 | Nov 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $31 → $34 | $39.34 | -13.57% | 2 | Nov 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $14 | $25.08 | -44.18% | 3 | Sep 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $10 | $3.96 | +152.53% | 12 | Aug 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $28 | $25.04 | +11.82% | 2 | Aug 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $15 → $14 | $14.80 | -5.41% | 13 | Jul 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $33 | $158.49 | -79.18% | 1 | Sep 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $990 → $180 | $1.55 | +11,512.90% | 2 | Mar 9, 2022 |
Health Catalyst
Feb 27, 2025
Maintains: Sector Perform
Price Target: $7 → $6
Current: $4.06
Upside: +47.78%
agilon health
Feb 26, 2025
Maintains: Outperform
Price Target: $3 → $3.5
Current: $2.45
Upside: +42.86%
IQVIA Holdings
Feb 10, 2025
Reiterates: Outperform
Price Target: $270
Current: $142.82
Upside: +89.05%
Teladoc Health
Jan 24, 2025
Maintains: Outperform
Price Target: $11 → $12
Current: $7.52
Upside: +59.57%
ICON Public Limited Company
Jan 15, 2025
Reiterates: Outperform
Price Target: $263
Current: $131.63
Upside: +99.80%
Evolent Health
Jan 14, 2025
Maintains: Outperform
Price Target: $20 → $17
Current: $8.83
Upside: +92.53%
Phreesia
Jan 8, 2025
Upgrades: Outperform
Price Target: $24 → $32
Current: $25.40
Upside: +25.98%
OptimizeRx
Jan 8, 2025
Downgrades: Sector Perform
Price Target: $7 → $6
Current: $11.43
Upside: -47.51%
HealthEquity
Dec 10, 2024
Maintains: Outperform
Price Target: $100 → $105
Current: $98.23
Upside: +6.89%
Sotera Health Company
Nov 21, 2024
Reiterates: Outperform
Price Target: $17
Current: $12.80
Upside: +32.81%
Nov 7, 2024
Maintains: Outperform
Price Target: $31 → $34
Current: $39.34
Upside: -13.57%
Sep 17, 2024
Reiterates: Outperform
Price Target: $14
Current: $25.08
Upside: -44.18%
Aug 16, 2024
Reiterates: Outperform
Price Target: $10
Current: $3.96
Upside: +152.53%
Aug 14, 2024
Reiterates: Outperform
Price Target: $28
Current: $25.04
Upside: +11.82%
Jul 25, 2024
Maintains: Outperform
Price Target: $15 → $14
Current: $14.80
Upside: -5.41%
Sep 14, 2022
Initiates: Outperform
Price Target: $33
Current: $158.49
Upside: -79.18%
Mar 9, 2022
Maintains: Sector Perform
Price Target: $990 → $180
Current: $1.55
Upside: +11,512.90%